INdustrycTceh INsight Logo

The FDA halted the J&J Covid vaccine’s use due to rare blood-clotting

The FDA halted the J&J Covid vaccine's use due to rare blood-clotting

April 15, 2021: -On Tuesday, the Food and Drug Administration asked states to temporarily pause using Johnson & Johnson’s Covid-19 vaccine “out of an abundance of caution” after six women in the U.S. developed a blood-clot disorder that left one woman dead, and left another in critical condition. “Right now, these adverse events are seen to be extremely rare,” the FDA said with the Canter’s for Disease Control and Prevention. “COVID-19 vaccine safety is the first priority for the federal government, and we take all reports of health problems follows COVID-19 vaccination very seriously.”

Jeffrey Zients, President Joe Biden’s Covid czar, said the halt would not have a “significant impact” on the administration’s goal to administer 200 million Covid doses within Biden’s first 100 days in office. He said J&J’s vaccine makes up lower than 5% of the recorded shots in arms in the U.S. to date.

J&J said that “no clear causal relationship” is identified between the blood clots and the vaccine and says it is working closely with regulators to assess the data.

People who receive the vaccine and “develop a serious headache, abdominal pain, leg pain, or breath shortage within three weeks after vaccination should contact their health care provider,” the FDA and CDC said.

On Wednesday, the CDC will conduct a meeting of the Advisory Committee on Immunization Practices to further review the cases, federal health regulators said on Tuesday. The FDA is also investigating the claims.

In February, J&J submitted its Covid vaccine data to the FDA, and no specific concerns were identified at the time while analysed by age, race, and comorbidities, according to the agency. The FDA said the most common were headache and fatigue, later follows by muscle pains, nausea, and fever.

It’s unclear how the pause will affect J&J’s goal to deliver 100 million doses to the U.S. by May end. The company has been plagued by manufacturing issues after a plant run by Emergent BioSolutions ruined 15 million doses of the vaccine.

Dr. Kavita Patel, a former federal health official, told CNBC she believes the FDA’s recommendation will have long-lasting impacts on the nation’s efforts to combat the pandemic.

Patel said the supply of the two-shot vaccines from Pfizer and Moderna wouldn’t be able to make up the demand created by the J&J pause quickly. This will delay U.S. vaccination efforts, she added.

Last week, Europe’s medicines regulator said it found a possible link between the coronavirus vaccine developed by AstraZeneca and the University of Oxford and rare blood-clotting issues. AstraZeneca has not received authorization for use in the U.S.

About Us

We provide the insights on leaders who are responsible for taking their organization to new heights, all the while bringing together a group of talented individuals.

Recent Posts

Transforming O&G Sector with AI | AspenTech

AspenTech, a Massachusetts-based company, plays a pivotal role in the oil and gas industry by leveraging cutting-edge technologies, including AI (artificial intelligence). Let’s delve into how AspenTech contributes to this dynamic sector

Enhancing Operational Efficiency by Providing Data Insight &Automation | Intelligent WellheadSystems

It’s no secret that oil and gas is a boom-and-bust industry. Production is currently up, projected to increase to 13.7 million barrels daily in 2024. But this won’t last forever. Whether production is up or down, the key to maximizing production, optimizing efficiency, and taking advantage of increased profits is innovation, digital transformation,and automation.For stakeholders looking to deliver safer, more efficient, and cheaper energy, innovation and automation must be a top priority. Those who fall behind in the race to innovate, ultimately, run the risk of losing market share.

Offering Limitless Possibilities To The O&G Industry | Advanced Upstream

Today oil and gas producers face severe regulatory and public relations obstacles due to the concern with greenhouse gases and resource depletion. Calgary-based start-up, Advanced Upstream (“AU”), has been disrupting the oil and gas industry with simple and reliable innovative technologies. AU’s products help the oil and gas producers to enhance energy production while reducing the corresponding environmental impact. By decreasing personnel and time on site, and lowering overall HSE risks across the board, the clients can see a notable improvement in their ESG rating, contributing to their bottom line.

Taking Advantage of Sustainable Energy | ABB Switzerland

Jasmin Staiblin, Chief Executive Officer of ABB Switzerland, says, “Global energy consumption continues to grow and, if left unabated, will lead to an ever-greater risk of irreversibly changing our climate. To take advantage of more sustainable energy sources, the energy landscape is in a state of profound change to allow the integration of increasing amounts of renewable energy sources into the grid, to allow infrastructure to run more intelligently and efficiently, and to ensure the supply of energy is available at all times.